Restrictive cardiomyopathy in India: The story of a vanishing mystery

Heart

Volumn 95, Issue 1, 2009, Pages 9-14

  Sivasankaran, S ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CERIUM; DIURETIC AGENT;

ANGIOGRAPHY; ARTICLE; CALCIFICATION; CLINICAL FEATURE; DISEASE CONTROL; ECHOCARDIOGRAPHY; ENDOCARDIUM; HEALTH STATUS; HEART CATHETERIZATION; HEART INJURY; HEART MUSCLE FIBROSIS; HISTORY; HUMAN; INDIA; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; RHEUMATIC FEVER; SOCIAL STATUS; SOIL ANALYSIS;

CALCINOSIS; CARDIOMYOPATHY, RESTRICTIVE; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HUMANS; INDIA; PREVALENCE; WORLD HEALTH;

EID: 58349088938     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.148437     Document Type: Article

References (45)

1. Weber KT. Fruits and soil: a case for the equatorial doctor in cardiovascular mystery series. Cardiovasc Res 1995; 30:635-6.
2. Tharakan J, Bohora S. Current perspectives on endomyocardial fibrosis Curr Sci (in press).
3. Bukhman G, Ziegler J, Parry L. Endomyocardial fibrosis: still a mystery after 60 years. PLoS Neglected Tropical Diseases 2008; 2:e97.
4. Vijayaraghavan G, Balakrishnan M, Sadanandan S, et al. Patterns of calcification in tropical endomyocardial fibrosis. Heart Vessels 1990; 5:S4-7
5. Balakrishnan V, Nair P, Radhakrishanan L, et al. Tropical pancreatitis? Indian J Gastroenterol 2006; 25:74-81.
6. Sandhyamoni S. Mucoid vasculopathy: vascular lesions in and autopsy study. Mod Pathol 1993; 6:333-41.
7. Shivakumar K, Nair RR, Kartha CC. The enigma of endomyocardial fibrosis. In: Radhakrishnan K, ed. Silver lines. Thiruvananthapuram, India: Sree Chitra Tirunal Institute for Medical Sciences and Technology 2004:121-32.
8. Gandhi VK, Dalai SB, Sharma JR, et al. Cardiomyopathy in children in Ahmedabad. Indian J Pediatr 1991; 58:665-70.
9. Seth S, Thatai D, Sharma S, et al. Clinico-pathological evaluation of restrictive cardiomyopathy in India. European J Heart Fail 2004; 6:723-9.
10. Sapru BP. Endomyocardial fibrosis in India. (ICMR workshop proceedings) 1981 In Endomyocardial fibrosis in India. ICMR, 1983.
11. Padmakumar B, Rao N, Tharakan J. A clinical overview of endomyocardial fibrosis In: Radhakrishnan K, ed. Silver lines. Thiruvananthapuram, India: Sree Chitra Tirunal Institute for Medical Sciences and Technology 2004:133-40.
12. Gupta PN, Valiathan MS, Balakrishnan KG, et al. Clinical course of endomyocardial fibrosis. Heart 1989; 62:450-4.
13. Kubo T, Gimeno RJ, Bahl A, et al. Prevalence, clinical significance and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 2007; 49:2419-26.
14. Ramankutty V, Abraham S, Kartha CC. Geographical distribution of endomyocardial fibrosis. Int J Epidemiol 1996; 25:1202-7.
15. Cox PR. Endomyocardial fibrosis and restrictive cardiomyopathy: pathologic and clinical features. J Vet Cardiol 2004; 6:25-31.
16. Sandhyamoni S. Mucoid vasculopathy and the nutritional imbalance metabolic syndrome. Radhakrishnan K, ed. Silver lines. Thiruvananthapuram, India: Sree Chitra Tirunal Institute for Medical Sciences and Technology 2004:141-54.
17. Anbarasu M, Manohar SR, Titus T, et al. One-and-a-half ventricular repair for right ventricular endomyocardial fibrosis. Asian Cardiovasc Thorac Ann 2004; 12:363-5.
18. Marojon E, Hausse AO. Ferreria B. Typical clinical aspect of endomyocardial fibrosis. Int J Cardiol 2006; 112:259-60.
19. Hassan WM, Fawzy ME, al Helaly S, et al. Pitfalls in diagnosis and clinical echocardographic and hemodynamic findings in endomyocardial fibrosis A 25-year experience. Chest 2005; 128:3985-92.
20. Balakrishanan KG, Sapru RP, Sasidharan K, et al. A comparison of clinical hemodynamic and angiographic features in right ventricular endomyocardial fibrosis and Ebstein's anomaly of the tricuspid valve. Cardiology 1982; 69:265-75.
21. Anonymous. Restrictive cardiomyopathy or constrictive pericarditis? Lancet 1987; 2:372-4.
22. Freers J, Mayanja-Kizza H, Rutakingirwa M, et al. Enodomyocardial fibrosis: why is there striking ascites with little or no pedal edema? Lancet 1996; 347:197.
23. Carlos A, Barretto P, Mady C, et al. Clinical meaning of ascites in patients with endomyocardial fibrosis. Arq Bras Cardiol 2002; 78:196-9.
24. Freers J, Masembe V, Schmauz R, et al. Endomyocardial fibrosis syndrome in Uganda. Lancet 2000; 355:1994-5.
25. Kartha CC. Endomyocardial fibrosis: a case for the trooical doctor. Cardiovasc Res 1995; 30:635-43.
26. Davies MJ. The cardiomyopathies: an overview. Heart 2000; 83:469-74.
27. Ogbogu P, Rosing DR, Home III MK. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27:457-75.
28. Schneider U, Jenni R, Turina J, et al. Long term follow up of patients with endomyocardial fibrosis: effects of surgery. Heart 1998: 79:362-7.
29. Kumar N, Prabhakar G, Fawzy ME, et al. Total cavopulmonary connection for right ventricular endomyocardial fibrosis. Eur J Cardiothorac Surg 1992; 6:391-2.
30. Estornell J, Lopez MP, Dicenta F, et al. [Usefulness of magnetic resonance imaging in the assessment of endomyocardial disease]. Rev Esp Cardiol 2003; 56:321-4.
31. Mousseaux E, Hernigou A, Azencot M, et al. Endomyocardial fibrosis: electronbeam CT features. Radiology 1996; 198:755-60.
32. Vijayaraghavan G, Cherian G, Krishnaswami S, Sikumar IP. Left ventricular endomyocardial fibrosis in India. Heart 1997; 39:563-8.
33. Vijayaraghavan G, Davies J, Sadanandan S, et al. Echocardiographic features of tropical endomyocardial disease in south India. Heart 1983; 50:450-9.
34. Mocumbi AO, Ferriera MB, Sidi D, et al. A population study of endomycardial fibrosis in a rural area of Mozambique. N Engl J Med 2008; 359:43-9.
35. Nath I, Reddy KS, Dinshaw KA, et al. Country profile: India. Lancet 1998; 351:1265-75
36. Sivasankaran S. The broadening waist line of the Keralites: the diet link. In: Kartha CC, ed. Kerala fifty years and beyond. Trivandrum: Gautha Books, 2007:307-44
37. Srivasatava S. Rheumatic heart disease: is it declining in India? Indian Heart J 2007; 59:9-10.
38. Zeisberg EM, Tarnavaski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-61.
39. Towbin JA. Scarring in the heart - a reversible phenomenon? N Engl J Med 2007; 357:1767-8.
40. Mayosi BM, Somers K. Cardiomyopathy in Africa: heredity versus environment Cardiovasc J Afr 2007; 18:175-9.
41. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 2007; 93:1176-83
42. Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies: II Endomyocaridal fibrosis: myocardial disease. Heart 2008; 94:384-90.
43. Farzaneh-Far A, Proudfoot D, Shananhan C, et al. Vascular and valvar calcification Recent advances. Heart 2001; 85:13-7.
44. Burke AP, Kolodgie FD, Virmani R, et al. Valve calcification, and diabetes. what do we understand? Circulation 2007; 115:2464-7.
45. Beisel WR. Herman award lecture, 1995: infection-induced malnutrition - from cholera to cytokines. Am J Clin Nutr 1995; 62:813-9.